✦ LIBER ✦

Imuthiol prevents against the depression of T-cell activities induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

✍ Scribed by G. Renoux; M. Renoux; K. Biziere

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 77 KB
Volume: 10
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(88)90220-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential neuroprotective effect of t-bu

Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity—Induced by 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-methyl-MPTP) in mice

✍ M. H. Abdel-Wahab 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

## Abstract Dopaminergic damage inducing Parkinson's disease (PD) is ubiquitous neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathways. The etiology and pathogenic factors implicated in dopaminergic damage are still unexplored to deve

Lesion of the subthalamic nucleus for th

Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate

✍ T. Z. Aziz; D. Peggs; M. A. Sambrook; Dr. A. R. Crossman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Central to the neural mechanism of MPTP-induced parkinsonism is overactivity of the subthalamic nucleus. Lesion of the subthalamic nucleus has therefore been performed in two primates with this condition and found to produce a remarkable amelioration of the disorder.

Mechanism of the neurotoxicity of 1-meth

Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP)+, the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

✍ Thomas P. Singer; Rona R. Ramsay; K. McKeown; A. Trevor; N.E. Castagnoli Jr. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 369 KB

The formation of reactive intermediates

The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

✍ A.J. Trevor; N. Castagnoli; T.P. Singer 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 380 KB

An appraisal of the antiparkinsonian act

An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets

✍ Lance Smith; Maria De Salvia; Prof. Peter Jenner; C. David Marsden 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

The D2 dopamine agonist piribedil is not widely used in the treatment of Parkinson's disease because it was thought to be effective mainly on parkinsonian tremor and to produce a high incidence of peripheral side effects, particular nausea. In this study, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydro

Nerve growth factor prevents 1-methyl-4-

Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: Relevance to therapeutical application for parkinson's disease

✍ Koji Shimoke; Hiroaki Chiba 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Nerve growth factor (NGF) mediates a variety of nerve cell actions through receptor tyrosine kinase TrkA. It has been revealed that the Akt pathway contributes to the prevention of apoptosis. It is thought that Parkinson's disease involves apoptosis, and NGF prevents apoptosis in an in vivo model sy